Skip to main content

Box 1 Eligibility criteria

From: Patient and public involvement in implementation of evidence-based guidance for musculoskeletal conditions: a scoping review of current advances and gaps

 

Inclusion criteria

Exclusion criteria

Conditions

Population: Guideline related to adults, 18 years and older with any MSK conditions

Studies among paediatric populations

Studies for other conditions or for which over 50% of patients were non-MSK

PPI participants

Studies reporting PPI recruitment, and involvement activities

Studies mentioning PPI but without any details of actual recruitment or PPI activities

Purpose (PPI) involvement

Guideline contextualisation to local/practice settings

PPI in guideline implementation

Consideration for health service planning/care organisation policy developments/

Monitoring and evaluation of guideline impact

Predominantly research

Predominantly guideline development process (e.g., mention of PPI as part of “stakeholder consensus” at development stage)

Articles evaluating the quality of guidelines with AGREE or any other instrument were not eligible

Outcomes of interest

Patient health related outcomes (e.g., Quality of life, shared decision making, acceptability)

Sustained adoption and use of guidelines in practice

Impact evaluation after guideline uptake (including impact on service delivery)

 
  1. The criteria are used to screen for eligible studies sequentially, in the following order:
  2. MSK Conditions y/n; PPI participants y/n; Purpose of involvement y/n; Outcomes y/n;
  3. A NO at any stage in the process leads to exclusion of the article
  4. No restrictions on study design /settings or language
Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us